Tags

Type your tag names separated by a space and hit enter

Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
Dermatol Online J. 2014 Aug 17; 20(8)DO

Abstract

Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

Authors+Show Affiliations

No affiliation info availableNagoya University Graduate School of Medicine.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

25148281

Citation

Ito, Eri, et al. "Hydroxyurea-induced Amyopathic Dermatomyositis Presenting With Heliotrope Erythema." Dermatology Online Journal, vol. 20, no. 8, 2014.
Ito E, Muro Y, Shibata A, et al. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. Dermatol Online J. 2014;20(8).
Ito, E., Muro, Y., Shibata, A., Sugiura, K., & Akiyama, M. (2014). Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. Dermatology Online Journal, 20(8).
Ito E, et al. Hydroxyurea-induced Amyopathic Dermatomyositis Presenting With Heliotrope Erythema. Dermatol Online J. 2014 Aug 17;20(8) PubMed PMID: 25148281.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. AU - Ito,Eri, AU - Muro,Yoshinao, AU - Shibata,Akitaka, AU - Sugiura,Kazumitsu, AU - Akiyama,Masashi, Y1 - 2014/08/17/ PY - 2014/08/15/received PY - 2014/08/15/accepted PY - 2014/8/23/entrez PY - 2014/8/26/pubmed PY - 2015/5/15/medline JF - Dermatology online journal JO - Dermatol Online J VL - 20 IS - 8 N2 - Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder. SN - 1087-2108 UR - https://www.unboundmedicine.com/medline/citation/25148281/Hydroxyurea_induced_amyopathic_dermatomyositis_presenting_with_heliotrope_erythema_ DB - PRIME DP - Unbound Medicine ER -